Cleerly LABS vs SignalHF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly LABS

by Cleerly

SignalHF

by Implicity

AI Verdict

Cleerly LABS is an AI-powered tool focused on analyzing coronary CT angiography to detect and characterize coronary artery disease, aiding in personalized management and heart attack prevention. In contrast, SignalHF by Implicity is an AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices. While both are FDA-cleared cardiology AI tools, Cleerly targets the diagnosis and progression of coronary artery disease, whereas SignalHF focuses on predictive analytics for acute heart failure events.

Choose Cleerly LABS if…

Choose Cleerly LABS if you need a comprehensive, AI-powered analysis of coronary CT angiography to detect, quantify, and characterize atherosclerosis and stenosis. This tool is ideal for proactively assessing a patient's cardiovascular risk, understanding the extent of coronary plaque burden, and guiding personalized heart disease management strategies based on detailed anatomical imaging.

View Cleerly LABS →

Choose SignalHF if…

Choose SignalHF if you are managing patients with existing heart failure who have cardiac implantable electronic devices and require predictive analytics to prevent hospitalizations. This AI algorithm is best suited for identifying patients at high risk of heart failure hospitalization within 30 days, enabling timely intervention and personalized care adjustments to avoid acute events.

View SignalHF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly LABS	SignalHF
Pricing	Varies	Contact for pricing
Deployment	Cloud, On-premise	SaaS
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly LABS	SignalHF
Name	Cleerly LABS	SignalHF
Company	Cleerly	Implicity
Description	AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management.	FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care.
Key Functionality	AI-powered CCTA image analysis, comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, personalized heart disease risk assessment, tracking disease progression over time, integration with PACS, RIS, EHR via Cleerly Proxy.	FDA-cleared AI algorithm for heart failure prediction, predicts heart failure hospitalizations within 30 days, manufacturer-agnostic compatibility with various CIEDs (pacemakers, ICDs, CRTs), analyzes physiological data, demographics, lead measurements, episodes, and therapies, generates automatic alerts for care teams based on risk scores, enables early intervention and personalized care plans, unified platform for centralizing cardiac implantable device data, AI-driven alert management to filter and highlight relevant events.

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and SignalHF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical problem each tool aims to solve?

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. SignalHF by Implicity is an AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from cardiac implantable electronic devices, enabling early intervention.

What type of patient data is required for each tool's analysis?

Cleerly LABS requires coronary CT angiography (CCTA) images for its AI-powered analysis. SignalHF analyzes physiological data, demographics, lead measurements, episodes, and therapies collected from various cardiac implantable electronic devices (CIEDs) such as pacemakers, ICDs, and CRTs.

What specific insights or outputs do these tools provide to physicians?

Cleerly LABS offers comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, 3D visualization of coronary arteries, and personalized heart disease risk assessment, with an optional ischemia detection module. SignalHF generates automatic alerts for care teams based on risk scores, predicting heart failure hospitalizations within 30 days.

Which patient populations are most appropriate for each tool?

Cleerly LABS is suitable for patients undergoing CCTA for evaluation of coronary artery disease (CAD) or suspected CAD, where comprehensive assessment of coronary plaques and stenosis is needed for personalized management. SignalHF is intended for patients over 18 years old with compatible cardiac implantable electronic devices (CIEDs) who are receiving physiological monitoring for heart failure surveillance.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly LABS or SignalHF

Backers

Who funded each tool's parent company.

Cleerly LABS

SignalHF

Serena